2632-8674

NAR Cancer

Oxford University Press

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 13 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact13 DOIs
2

Attach ORCID iDs across 13 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact13 DOIs
3

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 327 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Quantification of radiation-induced DNA double strand break… (10.1093/narcan/zcab046)
License
47.98 82
2 ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation… (10.1093/narcan/zcaa018)
ORCID
38.29 33
3 R-loops, type I topoisomerases and cancer (10.1093/narcan/zcad013)
License
36.18 27
4 PP2A and cancer epigenetics: a therapeutic opportunity waiti… (10.1093/narcan/zcac002)
ORCID
34.95 24
5 An emerging picture of FANCJ’s role in G4 resolution to faci… (10.1093/narcan/zcab034)
License
34.51 23
6 Characteristics of mutational signatures of unknown etiology (10.1093/narcan/zcaa026)
ORCID
32.53 19
7 m6A epitranscriptome analysis reveals differentially methyla… (10.1093/narcan/zcad054)
ORCID
28.65 13
8 Rewiring of RNA methylation by the oncometabolite fumarate i… (10.1093/narcan/zcae004)
License
25.00 9
9 Ribosomal RNA 2′ O-methylation as a novel layer of inter-tum… (10.1093/narcan/zcab006)
Abstract ORCID
23.86 2
10 Heterogeneity in the gene regulatory landscape of leiomyosar… (10.1093/narcan/zcad037)
ORCID
23.86 8
11 The uracil–DNA glycosylase UNG protects the fitness of norma… (10.1093/narcan/zcaa045)
Abstract References ORCID
22.58 1
12 The alternative lengthening of telomeres pathway through a D… (10.1093/narcan/zcaf056)
License
21.13 6
13 The role of Sp1 in the detection and elimination of cells wi… (10.1093/narcan/zcaa004)
ORCID
17.47 4
14 Correction to ‘Elucidation of the BMI1 interactome identifie… (10.1093/narcan/zcab020)
Abstract References
15.05 1
15 Correction to ‘Tumor-selective, antigen-independent delivery… (10.1093/narcan/zcab047)
Abstract References
15.05 1
16 Editorial: NAR Cancer and epigenetics and cancer (10.1093/narcan/zcac003)
Abstract ORCID
15.05 1
17 Human NTHL1 expression and subcellular distribution determin… (10.1093/narcan/zcae006)
License
15.05 3
18 Putatively cancer-specific exon–exon junctions are shared ac… (10.1093/narcan/zcaa001)
0.00 22
19 Combined cytotoxic chemotherapy and immunotherapy of cancer:… (10.1093/narcan/zcaa002)
0.00 223
20 CDK12: cellular functions and therapeutic potential of versa… (10.1093/narcan/zcaa003)
0.00 35
21 <i>SMARCA4</i>deficiency-associated heterochromatin induces… (10.1093/narcan/zcaa005)
0.00 49
22 Intrinsic ATR signaling shapes DNA end resection and suppres… (10.1093/narcan/zcaa006)
0.00 11
23 KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal inte… (10.1093/narcan/zcaa007)
0.00 12
24 Distinct roles of structure-specific endonucleases EEPD1 and… (10.1093/narcan/zcaa008)
0.00 13
25 Characterizing and classifying neuroendocrine neoplasms thro… (10.1093/narcan/zcaa009)
0.00 16
26 Proteome dynamics analysis identifies functional roles of SD… (10.1093/narcan/zcaa010)
0.00 14
27 Mechanistic models of signaling pathways deconvolute the gli… (10.1093/narcan/zcaa011)
0.00 12
28 Clinical and functional characterization of CXCR1/CXCR2 biol… (10.1093/narcan/zcaa012)
0.00 18
29 XRCC1 promotes replication restart, nascent fork degradation… (10.1093/narcan/zcaa013)
0.00 46
30 Synthetic circular miR-21 RNA decoys enhance tumor suppresso… (10.1093/narcan/zcaa014)
0.00 29
31 Pan-cancer proteogenomic analysis reveals long and circular… (10.1093/narcan/zcaa015)
0.00 23
32 A novel siRNA–gemcitabine construct as a potential therapeut… (10.1093/narcan/zcaa016)
0.00 8
33 Defining the mutation signatures of DNA polymerase θ in canc… (10.1093/narcan/zcaa017)
0.00 59
34 The uracil-DNA glycosylase UNG protects the fitness of norma… (10.1093/narcan/zcaa019)
0.00 14
35 Translation reprogramming by eIF3 linked to glioblastoma res… (10.1093/narcan/zcaa020)
0.00 13
36 Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA… (10.1093/narcan/zcaa021)
0.00 53
37 Replication protein A: a multifunctional protein with roles… (10.1093/narcan/zcaa022)
0.00 125
38 Single-nucleotide polymorphism of the DNA cytosine deaminase… (10.1093/narcan/zcaa023)
0.00 21
39 Regulation and pharmacological targeting of RAD51 in cancer (10.1093/narcan/zcaa024)
0.00 69
40 Addressing cancer signal transduction pathways with antisens… (10.1093/narcan/zcaa025)
0.00 23
41 The structure of APOBEC1 and insights into its RNA and DNA s… (10.1093/narcan/zcaa027)
0.00 26
42 DDX5 resolves R-loops at DNA double-strand breaks to promote… (10.1093/narcan/zcaa028)
0.00 76
43 Activation-induced cytidine deaminase localizes to G-quadrup… (10.1093/narcan/zcaa029)
0.00 21
44 SMDB: pivotal somatic sequence alterations reprogramming reg… (10.1093/narcan/zcaa030)
0.00 8
45 Global identification and characterization of tRNA-derived R… (10.1093/narcan/zcaa031)
0.00 24
46 The chemotherapeutic agent CX-5461 irreversibly blocks RNA p… (10.1093/narcan/zcaa032)
0.00 81
47 APOBEC3 enzymes mediate efficacy of cisplatin and are epista… (10.1093/narcan/zcaa033)
0.00 11
48 Unique <i>k</i> -mer… (10.1093/narcan/zcaa034)
0.00 10
49 Profiling of ribose methylations in ribosomal RNA from diffu… (10.1093/narcan/zcaa035)
0.00 50
50 Ribosomal RNA 2′O-methylation as a novel layer of inter-tumo… (10.1093/narcan/zcaa036)
0.00 74